Document is current
Any future updates will be listed below
-
Authors
Fogelman, Nia
Barreto, Shaina
McGowan, Colleen
Wemm, Stephanie E.
Sinha, Rajita https://orcid.org/0000-0003-3012-4349
-
Funding
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (R01-AA013892)
National Institute on Drug Abuse (R01-DA061995-01)
Yale Interdisciplinary Stress Center, Yale University (Yale Interdisciplinary Stress Center, Yale University)
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 13 November 2025
First Online: 9 December 2025
Declarations
:
: This study was conducted in compliance with all human research ethical standards. These include the following: disclosure of potential conflicts of interest reported above, as well as obtaining institutional review board approval from the Yale Human Investigation Committee and obtaining signed written informed consent to participate in the research study and all of its approved procedures by every subject as noted below.
: All participants provided informed consent with signed written consent acknowledging review of all study procedures and willingness to participate. This is also included in the Methods section on page 5, lines 21–23 above.
: The Yale institutional review and approval process which was met by the study being reported here includes approval of publication and the informed consent includes the consent of participants for study participation and publication of findings.
: Dr. Sinha has research collaborations with AELIS Farma, CT Pharma and Aptinyx, Inc., and she is a scientific consultant and advisor to Imbrium Therapeutics, LLC. No other authors have conflicts of interest to disclose.
: The authors have no financial or proprietary interests in any material discussed in this article.
